MIR483

Gene Information
 
Gene Symbol
MIR483
 
Aliases
MIRN483, hsa-mir-483, mir-483
 
Entrez Gene ID
 
Gene Name
MicroRNA 483
 
Chromosomal Location
11p15.5
 
HGNC ID
 
Summary
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0035195 Biological process Gene silencing by miRNA IDA 22223106
GO:0035278 Biological process MiRNA mediated inhibition of translation IDA 21893058
GO:0090051 Biological process Negative regulation of cell migration involved in sprouting angiogenesis IMP 21893058
GO:1903588 Biological process Negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis IMP 21893058
GO:1903231 Molecular function MRNA binding involved in posttranscriptional gene silencing IDA 21893058, 22223106
Pathways
 
KEGG
 
 

MicroRNAs in cancer

 

Associated Diseases

Disease groupDisease NameReferences
Digestive System Diseases
Liver Diseases
Liver Cirrhosis
Hepatitis
Endocrine System Diseases
Diabetes Mellitus
PCOS
References
 

miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome.

Shi Lin, Liu Shan, Zhao Wanqiu, Shi Juanzi
Department of Immunology and Microbiology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.| Assisted Reproduction Center, Maternal and Child Health Care Hospital of Shaanxi Province, Xi'an 710003, China.| Assisted Reproduction Center, Maternal and Child Health Care Hospital of Shaanxi Province, Xi'an 710003, China.| Assisted Reproduction Center, Maternal and Child Health Care Hospital of Shaanxi Province, Xi'an 710003, China. Electronic address: shijuanzi123@126.com.
Reprod Biomed Online. 2015 Oct;31(4):565-72. doi: 10.1016/j.rbmo.2015.06.023.

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412